Radioimmunotherapy: A Novel Treatment Modality for B-Cell Non-Hodgkin's Lymphoma

Cancer Biotherapy & RadiopharmaceuticalsVol. 18, No. 5 EditorialRadioimmunotherapy: A Novel Treatment Modality for B-Cell Non-Hodgkin's LymphomaMalik Juweid, Gerald L. DeNardo, Michael Graham, and Julie VoseMalik JuweidSearch for more papers by this author, Gerald L. DeNardoSearch for more papers by this author, Michael GrahamSearch for more papers by this author, and Julie VoseSearch for more papers by this authorPublished Online:5 Jul 2004https://doi.org/10.1089/108497803770418229AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail "Radioimmunotherapy: A Novel Treatment Modality for B-Cell Non-Hodgkin's Lymphoma." , 18(5), pp. 673–674FiguresReferencesRelatedDetailsCited ByTargeted Radionuclide TherapyExtranodal non-Hodgkin's lymphoma in the malar region - a case report31 October 2011 | Oral Surgery, Vol. 5, No. 1Targeted Radionuclide Therapy—Expanded ContentCurrent and future aspects of nuclear molecular therapies: A model of theranosticsMethods, Vol. 55, No. 3Rational Design and Generation of a Bimodal Bifunctional Ligand for Antibody-Targeted Radiation Cancer Therapy7 December 2007 | Journal of Medicinal Chemistry, Vol. 51, No. 1Systemic Targeted Radionuclide Therapy symposium introductionInternational Journal of Radiation Oncology*Biology*Physics, Vol. 66, No. 2Molecular Nuclear Imaging: The Radiopharmaceuticals (Review) Seyed K. Imam3 May 2005 | Cancer Biotherapy & Radiopharmaceuticals, Vol. 20, No. 2 Volume 18Issue 5Oct 2003 To cite this article:Malik Juweid, Gerald L. DeNardo, Michael Graham, and Julie Vose.Radioimmunotherapy: A Novel Treatment Modality for B-Cell Non-Hodgkin's Lymphoma.Cancer Biotherapy and Radiopharmaceuticals.Oct 2003.673-674.http://doi.org/10.1089/108497803770418229Published in Volume: 18 Issue 5: July 5, 2004PDF download